Affiliation:
1. Susan B Meister Child Health Evaluation and Research Center Department of Pediatrics University of Michigan Ann Arbor Michigan USA
2. Department of Pediatrics Baylor College of Medicine Houston Texas USA
3. Center for Child Health Policy and Advocacy Texas Children's Hospital Houston Texas USA
4. Department of Biostatistics School of Public Health University of Michigan Ann Arbor Michigan USA
5. Department of Epidemiology School of Public Health University of Michigan Ann Arbor Michigan USA
Abstract
AbstractBackground and objectiveNational guidelines recommend that children with sickle cell anemia (SCA) be seen regularly by primary care providers (PCPs) as well as hematologists to receive comprehensive, multidisciplinary care. The objective is to characterize the patterns of primary and hematology care for children with SCA in Michigan.MethodsUsing validated claims definitions, children ages 1–17 years with SCA were identified using Michigan Medicaid administrative claims from 2010 to 2018. We calculated the number of outpatient PCP and hematologist visits per person‐year, as well as the proportion of children with at least one visit to a PCP, hematologist, or both a PCP and hematologist annually. Negative binomial regression was used to calculate annual rates of visits for each provider type.ResultsA total of 875 children contributed 2889 person‐years. Of the total 22,570 outpatient visits, 52% were with a PCP and 34% with a hematologist. Annually, 87%–93% of children had a visit with a PCP, and 63%–85% had a visit with a hematologist. Approximately 66% of total person‐years had both visit types within a year. The annual rate ranged from 2.3 to 2.5 for hematologist visits and from 3.7 to 4.1 for PCP visits.ConclusionsSubstantial gaps exist in the receipt of annual hematology care. Given that the majority of children with SCA see a PCP annually, strategies to leverage primary care visits experienced by this population may be needed to increase receipt of SCA‐specific services.
Reference52 articles.
1. CDC.Data & statistics on sickle cell disease.CDC;2020. Accessed December 18 2020.https://www.cdc.gov/ncbddd/sicklecell/data.html
2. CDC.Complications of sickle cell disease.Centers for Disease Control and Prevention;2022. Accessed June 21 2022.https://www.cdc.gov/ncbddd/sicklecell/complications.html?CDC_AA_refVal=
3. National Heart Lung and Blood Institute.Evidence‐based management of sickle cell disease: expert panel report 2014.National Institutes of Health;2014.
4. Healthcare utilization and expenditures for low income children with sickle cell disease